Remote endarterectomy versus supragenicular bypass surgery for long occlusions of the superficial femoral artery: Medium-term results of a randomized controlled trial (The REVAS trial)

Annals of Vascular Surgery

Volumn 24, Issue 8, 2010, Pages 1015-1023

  Gisbertz, Suzanne S ^a   Tutein Nolthenius, Rudolf P ^b   De Borst, Gert Jan ^c   Van Der Laan, Lyckle ^d   Overtoom, Tim Th C ^a   Moll, Frans L ^c   De Vries, Jean Paul P M ^a  

^a ST ANTONIUS HOSPITAL   (Netherlands)

^b ALBERT SCHWEITZER HOSPITAL   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d AMPHIA HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; COUMARIN; DIPYRIDAMOLE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGED; ARTERY BYPASS; ARTERY OCCLUSION; ARTICLE; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENDARTERECTOMY; FEMALE; GRAFT PATENCY; HUMAN; INTERMITTENT CLAUDICATION; LIMB SALVAGE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SUPERFICIAL FEMORAL ARTERY; SURVIVAL RATE; VEIN GRAFT;

ADULT; AGED; AGED, 80 AND OVER; ARTERIAL OCCLUSIVE DISEASES; BLOOD VESSEL PROSTHESIS; BLOOD VESSEL PROSTHESIS IMPLANTATION; CHI-SQUARE DISTRIBUTION; CONSTRICTION, PATHOLOGIC; ENDARTERECTOMY; FEMALE; FEMORAL ARTERY; HUMANS; INTERMITTENT CLAUDICATION; ISCHEMIA; KAPLAN-MEIER ESTIMATE; LIMB SALVAGE; MALE; MIDDLE AGED; NETHERLANDS; POLYTETRAFLUOROETHYLENE; PROPORTIONAL HAZARDS MODELS; PROSTHESIS DESIGN; REOPERATION; RISK ASSESSMENT; RISK FACTORS; SAPHENOUS VEIN; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME; VASCULAR GRAFTING; VASCULAR PATENCY;

EID: 78049446470     PISSN: 08905096     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.avsg.2010.03.022     Document Type: Article

References (40)

1. L. Norgren, W.R. Hiatt, and J.A. Dormandy Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II) J Vasc Surg 45 Suppl. S 2007 S5 S67
2. C.P. Twine, J. Coulston, and A. Shandall Angioplasty versus stenting for superficial femoral artery lesions Cochrane Database Syst Rev 2009 CD006767
3. E.S. van der Zaag, D.A. Legemate, and M.H. Prins Angioplasty or bypass for superficial femoral artery disease? A randomised controlled trial Eur J Vasc Endovasc Surg 28 2004 132 137
4. H. Krankenberg, M. Schluter, and H.J. Steinkamp Nitinol stent implantation versus percutaneous transluminal angioplasty in superficial femoral artery lesions up to 10 cm in length: the Femoral Artery Stenting Trial (FAST) Circulation 116 2007 285 292
5. A. Bolia Subintimal angioplasty in lower limb ischaemia J Cardiovasc Surg (Torino) 46 2005 385 394
6. N. Mamode, and R.N. Scott Graft type for femoro-popliteal bypass surgery Cochrane Database Syst Rev 2000 CD001487
7. S. Roll, J. Müller-Nordhorn, and T. Keil Dacron vs. PTFE as bypass materials in peripheral vascular surgery - systematic review and meta-analysis BMC Surg 8 2008 22
8. C. Devine, and C. McCollum Heparin-bonded Dacron or polytetrafluorethylene for femoropopliteal bypass: five-year results of a prospective randomized multicenter clinical trial J Vasc Surg 40 2004 924 931
9. L.P. Jensen, M. Lepantalo, and J.E. Fossdal Dacron or PTFE for above-knee femoropopliteal bypass. A multicenter randomised study Eur J Vasc Endovasc Surg 34 2007 44 49
10. P. Klinkert, A. Schepers, and D.H. Burger Vein versus polytetrafluoroethylene in above-knee femoropopliteal bypass grafting: five-year results of a randomized controlled trial J Vasc Surg 37 2003 149 155
11. P. Klinkert, P.N. Post, and P.J. Breslau Saphenous vein versus PTFE for above-knee femoropopliteal bypass. A review of the literature Eur J Vasc Endovasc Surg 27 2004 357 362
12. W.C. Johnson, and K.K. Lee A comparative evaluation of polytetrafluoroethylene, umbilical vein, and saphenous vein bypass grafts for femoral-popliteal above-knee revascularization: a prospective randomized Department of Veterans Affairs cooperative study J Vasc Surg 32 2000 268 277
13. C.E. Pereira, M. Albers, and M. Romiti Meta-analysis of femoropopliteal bypass grafts for lower extremity arterial insufficiency J Vasc Surg 44 2006 510 517
14. R.M. Green, W.M. Abbott, and T. Matsumoto Prosthetic above-knee femoropopliteal bypass grafting: five-year results of a randomized trial J Vasc Surg 31 2000 417 425
15. G.H. Ho, F.L. Moll, and P.P. Joosten The Mollring Cutter remote endarterectomy: preliminary experience with a new endovascular technique for treatment of occlusive superficial femoral artery disease J Endovasc Surg 2 1995 278 287
16. D. Rosenthal, J.D. Martin, and P.J. Schubart Remote superficial femoral artery endarterectomy and distal aSpire stenting: multicenter medium-term results J Vasc Surg 40 2004 67 72
17. D. Rosenthal, J.D. Martin, and L. Smeets Remote superficial femoral artery endarterectomy and distal aSpire stenting: results of a multinational study at three-year follow-up J Cardiovasc Surg (Torino) 47 2006 385 391
18. G.A. Antoniou, S. Koutsias, and S.A. Antoniou Remote endarterectomy for long segment superficial femoral artery occlusive disease. A systematic review Eur J Vasc Endovasc Surg 36 2008 310 318
19. S.S. Gisbertz, M. Ramzan, and R.P. Tutein Nolthenius Short-term results of a randomized trial comparing remote endarterectomy and supragenicular bypass surgery for long occlusions of the superficial femoral artery [the REVAS trial] Eur J Vasc Endovasc Surg 37 2009 68 76
20. R.B. Rutherford, J.D. Baker, and C. Ernst Recommended standards for reports dealing with lower extremity ischemia: revised version J Vasc Surg 26 1997 517 538
21. G.H. Ho, P.A. van Buren, and F.L. Moll The importance of revision of early restenosis after endovascular remote endarterectomy in SFA occlusive disease Eur J Vasc Endovasc Surg 19 2000 35 42
22. A.P. Moody, P.R. Edwards, and P.L. Harris In situ versus reversed femoropopliteal vein grafts: long-term follow-up of a prospective, randomized trial Br J Surg 79 1992 750 752
23. A. Schanzer, N. Hevelone, and C.D. Owens Technical factors affecting autogenous vein graft failure: observations from a large multicenter trial J Vasc Surg 46 2007 1180 1190
24. D.H. Burger, A.P. Kappetein, and J.H. Van Bockel A prospective randomized trial comparing vein with polytetrafluoroethylene in above-knee femoropopliteal bypass grafting J Vasc Surg 32 2000 278 283
25. W.M. Abott, R.M. Green, and T. Matsumoto Above-Knee Femoropopliteal Study Group Prosthetic above-knee femoropopliteal bypass grafting: results of a multicenter randomized prospective trial J Vasc Surg 25 1997 19 28
26. D. Rosenthal, R.D. Evans, and J. McKinsey Prosthetic above-knee femoropopliteal bypass for intermittent claudication J Cardiovasc Surg (Torino) 31 1990 462 468
27. L. Smeets, H.J. Huijbregts, and G.H. Ho Clinical outcome after re-occlusion of initially successful remote endarterectomy of the superficial femoral artery J Cardiovasc Surg (Torino) 48 2007 309 314
28. L. Smeets, G.H. Ho, and T. Hagenaars Remote endarterectomy: first choice in surgical treatment of long segmental SFA occlusive disease? Eur J Vasc Endovasc Surg 25 2003 583 589
29. G.H. Ho, P.A. van Buren, and F.L. Moll Incidence, time-of-onset, and anatomical distribution of recurrent stenoses after remote endarterectomy in superficial femoral artery occlusive disease J Vasc Surg 30 1999 106 113
30. E.P. Strecker, I.B. Boos, and D. Göttmann Clopidogrel plus long-term aspirin after femoro-popliteal stenting. The CLAFS project: 1- and 2-year results Eur Radiol 14 2004 302 308
31. J. Dörffler-Melly, M.M. Koopman, and M.H. Prins Antiplatelet and anticoagulant drugs for prevention of restenosis/reocclusion following peripheral endovascular treatment Cochrane Database Syst Rev 2005 CD002071
32. CAPRIE Steering Committee A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE) Lancet 348 1996 1329 1339
33. A.J. Comerota Effect on platelet function of cilostazol, clopidogrel, and aspirin, each alone or in combination Atheroscler Suppl 6 2005 13 19
34. Y. Cadroy, J.P. Bossavy, and C. Thalamus Early potent antithrombotic effect with combined aspirin and a loading dose of clopidogrel on experimental arterial thrombogenesis in humans Circulation 101 2000 2823 2828
35. R. Morishita A scientific rationale for the CREST trial results: evidence for the mechanism of action of cilostazol in restenosis Atheroscler Suppl 6 2005 41 46
36. S. Goto Cilostazol: potential mechanism of action for antithrombotic effects accompanied by a low rate of bleeding Atheroscler Suppl 6 2005 3 11
37. P. Robless, D.P. Mikhailidis, and G.P. Stansby Cilostazol for peripheral arterial disease Cochrane Database Syst Rev 2008 CD003748
38. G. Tepe, T. Zeller, and T. Albrecht Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg N Engl J Med 358 2008 689 699
39. J. Berglund, M. Björck, J. Elfström SWEDVASC Femoro-popliteal Study Group Long-term results of above knee femoro-popliteal bypass depend on indication for surgery and graft-material Eur J Vasc Endovasc Surg 29 2005 412 418
40. M. Lenti, E. Cieri, and P. De Rango Endovascular treatment of long lesions of the superficial femoral artery: results from a multicenter registry of a spiral, covered polytetrafluoroethylene stent J Vasc Surg 45 2007 32 39